Back | Next |
home / stock / opht / opht message board
Subject | By | Source | When |
---|---|---|---|
https://seekingalpha.com/article/4100709-ophthotech-3-strikes | Inoviorulez | investorshub | 08/21/2017 8:57:18 PM |
thank you! | PStockPickz | investorshub | 08/08/2017 12:54:11 PM |
Still $5 cash per share, Zimura and a | naturalborninvestor | investorshub | 08/08/2017 12:48:14 PM |
Anything left here? Looks like nothing but failure | PStockPickz | investorshub | 08/06/2017 12:20:13 PM |
more filings yesterday | toytundra | investorshub | 07/11/2017 3:01:54 PM |
Daily not so much, but other ind.s turning up | Wildbilly | investorshub | 07/05/2017 9:59:21 AM |
$OPHT weekly chart | naturalborninvestor | investorshub | 07/02/2017 10:31:50 PM |
Toute est possible... | Klinsmann | investorshub | 06/30/2017 5:25:55 PM |
I feel confident there will be some sort | naturalborninvestor | investorshub | 06/30/2017 5:14:09 PM |
Its a loooong and unexpected hard way back | Klinsmann | investorshub | 06/30/2017 4:51:55 PM |
Just added. Trading at 50% year end 2017 | naturalborninvestor | investorshub | 06/30/2017 4:41:39 PM |
3.00 on the way | toytundra | investorshub | 06/23/2017 2:26:29 PM |
Reversal in the making - looking good right now | Klinsmann | investorshub | 06/19/2017 5:36:16 PM |
looking good, shorts will run it to 5 | buylow2 | investorshub | 06/19/2017 4:32:49 PM |
Looks like someone is buying. | toytundra | investorshub | 06/15/2017 2:26:00 PM |
Very nice day for $OPHT, slow but steady | Klinsmann | investorshub | 06/14/2017 4:36:32 PM |
I have taken a beating on this one | toytundra | investorshub | 06/14/2017 2:45:32 PM |
keep seeing all these funds buying in, I'm | buylow2 | investorshub | 06/13/2017 3:33:04 PM |
ARMISTICE CAPITAL, LLC has filed a new 13G, | wiltonio | investorshub | 06/12/2017 7:51:36 PM |
At least 2,40+ holding to FINALLY ;) create | Klinsmann | investorshub | 06/08/2017 1:42:20 PM |
News, Short Squeeze, Breakout and More Instantly...
Ophthotech Corporation Company Name:
OPHT Stock Symbol:
NASDAQ Market:
Ophthotech Corporation Website:
- Company’s Shares Will Trade Under New Ticker Symbol: ISEE – Ophthotech Corporation (Nasdaq:OPHT) today announced that as part of its transition strategy to focus on discovering and developing novel gene therapy solutions to treat orphan inherited retinal diseases (IR...
Ophthotech Corporation (NASDAQ: OPHT) announced today that the Company has converted its option and entered into an exclusive global license agreement with the University of Pennsylvania (Penn), including the Perelman School of Medicine at the University of Pennsylvania and the University ...
Ophthotech Corporation (Nasdaq: OPHT) announced today that Kourous A. Rezaei, M.D., Chief Medical Officer, will present an overview of the Company at the Alliance for Regenerative Medicine’s (ARM) 7 th Annual Cell and Gene Therapy Investor Day in New York, NY, on Thursday, March 21...